ISGE Statement and Actions Taken for Assessing the Risk of Laparoscopic Morcellation of Occulted Sarcomas During Hysterectomy and Myomectomy.
Uterine leiomyoma is the most common benign gynecologic neoplasm that affects women of reproductive age [1]. Surgical procedures commonly employed to treat symptomatic uterine fibroids include myomectomy or total or sub-total hysterectomy. When performed using minimally invasive techniques, these procedures reduce the risks of intraoperative and postoperative morbidity and mortality [2]; although, in order to remove these bulky lesions from the abdominal cavity through laparoscopic ports it has to be used a laparoscopic power morcellator, a device with rapidly spinning blades to cut the uterine tissue into fragments so that it can be removed through a small incision [3]…
